Psoriasis
Pro Research Analysisby 
Searched over 200M research papers for "psoriasis"
Understanding Psoriasis: Pathogenesis, Clinical Features, and Treatment Options
Introduction to Psoriasis: Immune-Mediated Inflammatory Disorder
Psoriasis is a chronic, immune-mediated inflammatory disorder that primarily affects the skin, leading to the development of erythematous, scaling patches and plaques. It can manifest at any age and varies in severity, often involving the nails and joints, leading to psoriatic arthritis in some patients Patel1906Korman2019. The visible nature of psoriasis can significantly impact the personal and professional lives of those affected .
Pathogenesis of Psoriasis: Immune System and Genetic Factors
Immune System Involvement
The pathogenesis of psoriasis involves a complex interplay between the innate and adaptive immune systems. Key players include T cells, dendritic cells, macrophages, and keratinocytes, which interact through cytokines such as TNF-α, IL-23, and IL-17 Griffiths2007Rendon2019Kamiya2019. These interactions lead to the chronic inflammation characteristic of psoriasis Griffiths2007Rendon2019.
Genetic Predisposition
Genetic factors also play a crucial role in psoriasis. Genome-wide association studies have identified several genetic loci associated with psoriasis, including HLA-Cw6, which is particularly linked to early-onset psoriasis Stuart2015Griffiths2007. Differences in genetic risk factors have been noted between cutaneous-only psoriasis (PsC) and psoriatic arthritis (PsA), with specific variants more strongly associated with each condition .
Clinical Features and Comorbidities
Clinical Manifestations
Psoriasis presents in various forms, with chronic plaque psoriasis (psoriasis vulgaris) being the most common, accounting for 90% of cases . Other forms include pustular and erythrodermic psoriasis . The disease can significantly impair quality of life and is often associated with depressive illness .
Comorbid Conditions
Psoriasis is increasingly recognized as a systemic inflammatory disorder with several comorbidities. These include cardiovascular disease, diabetes mellitus, obesity, inflammatory bowel disease, and nonalcoholic fatty liver disease Korman2019Tokuyama2020. The shared inflammatory pathways and genetic susceptibilities contribute to these associations .
Advances in Treatment: Biologics and Systemic Agents
Biologic Treatments
Recent advances in understanding the pathogenesis of psoriasis have led to the development of targeted biologic therapies. These include TNF-α inhibitors (e.g., infliximab, adalimumab), IL-23 inhibitors (e.g., ustekinumab, guselkumab), and IL-17 inhibitors (e.g., secukinumab, ixekizumab) Rendon2019Yamanaka2021. These biologics have shown high efficacy in achieving significant skin clearance (PASI 90) in patients with moderate-to-severe psoriasis .
Systemic Pharmacological Treatments
Systemic treatments, including non-biological agents and small molecules, are also used to manage psoriasis. A network meta-analysis has shown that biologics, particularly anti-IL17, anti-IL12/23, and anti-IL23, are more effective than non-biological systemic agents in achieving skin clearance . However, the long-term safety and efficacy of these treatments require further investigation .
Conclusion
Psoriasis is a multifaceted disease with a complex pathogenesis involving immune and genetic factors. It presents significant clinical challenges due to its chronic nature and associated comorbidities. Advances in biologic therapies have revolutionized the management of psoriasis, offering targeted and effective treatment options. Ongoing research is essential to further understand the disease mechanisms and improve long-term treatment outcomes.
Sources and full results
Most relevant research papers on this topic
Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture.
Psoriatic arthritis and cutaneous psoriasis share some genetic risk factors, but there are also differences in their pathogenesis.
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Non-biological systemic agents, small molecules, and biologics show varying efficacy and safety in treating moderate-to-severe plaque psoriasis, with biologics showing the highest safety and effectiveness.
Pathophysiology of psoriasis: A review
Psoriasis is a complex chronic inflammatory skin disease caused by multiple genetic risk factors, environmental risk factors, and excessive immunological abnormalities, with a role for IL-17 and IL-23p19 in its pathogenesis.
Try another search
What are the basic principles of electricity and magnetism?
What are the effects of caffeine consumption on athletic performance and health?
What are the best treatments for influenza?
What are the best exercises for staying fit after 50?
What are the implications of sedentary lifestyles for health, and how can active habits be cultivated?
What are the causes and consequences of cultural heritage preservation?